2/24/2006

A new study reports the combination anti-cholesterol drugs simvastatin and ezetimibe in Vytorin, made by Merck/Schering-Plough Pharmaceuticals, is no more damaging to muscles than simvastatin alone.

Full Story:
Yahoo!

Related Summaries